Added to YB: 2025-09-16
Pitch date: 2025-09-12
NOVO-B.CO [neutral]
Novo Nordisk A/S
-30%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products.
Market Cap
DKK 1.1T
Pitch Price
DKK 338.42
Price Target
N/A
Dividend
4.94%
EV/EBITDA
7.46
P/E
10.29
EV/Sales
3.74
Sector
Pharmaceuticals
Category
turnaround
Show full summary:
Theodosian Capital | NOVOB – Restructuring
NOVO-B.CO (update): Restructuring cuts 9,000 jobs (11.5% of workforce) to save DKK8bn annually by end-2026; DKK8bn one-off charge. FY op profit growth 4-10% post-charge. Headcount grew 70% since 2020, costs too fast. Trading 13.1x 2026 consensus earnings, 3.9% yield. Quality entry point.
Read full article (1 min)